tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LIPO Stock Latest News

Lipella Pharmaceuticals Announces Nasdaq Delisting
Company AnnouncementsLipella Pharmaceuticals Announces Nasdaq Delisting
3M ago
8K
LIPO
Lipella Pharmaceuticals Faces Nasdaq Delisting
PremiumCompany Announcements
Lipella Pharmaceuticals Faces Nasdaq Delisting
3M ago
8K
LIPO
Lipella Pharmaceuticals announces U.S. patent issuance for diagnostic tech
PremiumThe Fly
Lipella Pharmaceuticals announces U.S. patent issuance for diagnostic tech
3M ago
LIPO
Lipella Pharmaceuticals Announces 2025 Stockholders Meeting Date
PremiumCompany Announcements
Lipella Pharmaceuticals Announces 2025 Stockholders Meeting Date
3M ago
8K
LIPO
Lipella Pharmaceuticals re-signs manufacturing collab with Cook MyoSite
PremiumThe Fly
Lipella Pharmaceuticals re-signs manufacturing collab with Cook MyoSite
3M ago
LIPO
Lipella Pharmaceuticals Faces Nasdaq Compliance Challenge
PremiumCompany AnnouncementsLipella Pharmaceuticals Faces Nasdaq Compliance Challenge
4M ago
8K
LIPO
Lipella Pharmaceuticals Presents Promising Phase 2a Trial Data
Premium
Company Announcements
Lipella Pharmaceuticals Presents Promising Phase 2a Trial Data
4M ago
8K
LIPO
Lipella Pharmaceuticals to present Phase 2a data for LP-310
Premium
The Fly
Lipella Pharmaceuticals to present Phase 2a data for LP-310
4M ago
LIPO
Lipella Reports Statistically Significant Results from Second Cohort in LP-310 Phase 2a Trial for Oral Lichen Planus
PremiumTipRanks Newswire
Lipella Reports Statistically Significant Results from Second Cohort in LP-310 Phase 2a Trial for Oral Lichen Planus
5M ago
LIPO
Lipella abstract on LP-10 for OLP accepted for presentation at AAOM, EAOM
PremiumThe Fly
Lipella abstract on LP-10 for OLP accepted for presentation at AAOM, EAOM
5M ago
LIPO
Lipella Pharmaceuticals announces results from second cohort of LP-310 trial
PremiumThe Fly
Lipella Pharmaceuticals announces results from second cohort of LP-310 trial
5M ago
LIPO
Lipella Pharmaceuticals completes enrollment in LP-310 trial
PremiumThe Fly
Lipella Pharmaceuticals completes enrollment in LP-310 trial
5M ago
LIPO
Lipella Pharmaceuticals files to sell 5.62M shares of common stock for holders
PremiumThe FlyLipella Pharmaceuticals files to sell 5.62M shares of common stock for holders
6M ago
LIPO
3 Penny Stocks to Watch Now, 2/13/25
Premium
Market News
3 Penny Stocks to Watch Now, 2/13/25
7M ago
CYN
LIPO
Lipella Pharmaceuticals Gains Buy Rating from Jason McCarthy Following Positive Phase 2a Results for LP-310
Premium
Ratings
Lipella Pharmaceuticals Gains Buy Rating from Jason McCarthy Following Positive Phase 2a Results for LP-310
7M ago
LIPO
Lipella Pharmaceuticals Gains FDA Approval for LP-310
PremiumCompany Announcements
Lipella Pharmaceuticals Gains FDA Approval for LP-310
7M ago
8K
LIPO
Morning Movers: Lattice Semiconductor, SelectQuote jump after earnings reports
PremiumThe Fly
Morning Movers: Lattice Semiconductor, SelectQuote jump after earnings reports
7M ago
KO
MAR
Lipella Pharmaceuticals reports ‘positive’ results from Phase 2a LP-310 trial
PremiumThe Fly
Lipella Pharmaceuticals reports ‘positive’ results from Phase 2a LP-310 trial
7M ago
LIPO
Lipella Pharmaceuticals Receives Buy Rating Amidst Promising FDA Approval and Strategic Financial Moves
PremiumRatings
Lipella Pharmaceuticals Receives Buy Rating Amidst Promising FDA Approval and Strategic Financial Moves
7M ago
LIPO
Lipella Pharmaceuticals announces publication in CUREUS
PremiumThe FlyLipella Pharmaceuticals announces publication in CUREUS
9M ago
LIPO
Lipella Pharmaceuticals completes dosing for first cohort in LP-310 trial
Premium
The Fly
Lipella Pharmaceuticals completes dosing for first cohort in LP-310 trial
10M ago
LIPO
Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges
Premium
Company Announcements
Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges
10M ago
LIPO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >